These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34107326)

  • 1. SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama.
    Díaz Y; Ortiz A; Weeden A; Castillo D; González C; Moreno B; Martínez-Montero M; Castillo M; Vasquez G; Sáenz L; Franco D; Pitti Y; Chavarria O; Gondola J; Moreno AM; Ábrego L; Beltrán D; Guerra I; Chang J; Chaverra Z; Guerrero I; Valoy A; Gaitán M; Araúz D; Morán E; Chen-Germán M; Valdespino E; Rodríguez R; Corrales R; Chen-Camaño R; Pascale JM; Martínez AA; López-Vergès S;
    Int J Infect Dis; 2021 Jul; 108():588-591. PubMed ID: 34107326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
    Nonaka CKV; Franco MM; Gräf T; de Lorenzo Barcia CA; de Ávila Mendonça RN; de Sousa KAF; Neiva LMC; Fosenca V; Mendes AVA; de Aguiar RS; Giovanetti M; de Freitas Souza BS
    Emerg Infect Dis; 2021 May; 27(5):1522-1524. PubMed ID: 33605869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
    Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
    Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants.
    Tchesnokova V; Kulasekara H; Larson L; Bowers V; Rechkina E; Kisiela D; Sledneva Y; Choudhury D; Maslova I; Deng K; Kutumbaka K; Geng H; Fowler C; Greene D; Ralston J; Samadpour M; Sokurenko E
    J Clin Microbiol; 2021 Oct; 59(11):e0092121. PubMed ID: 34379531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emergence of the New P.4 Lineage of SARS-CoV-2 With Spike L452R Mutation in Brazil.
    Bittar C; Possebon FS; Ullmann LS; Geraldini DB; da Costa VG; de Almeida LGP; da S Sanches PR; Nascimento-Júnior NM; Cilli EM; Artico Banho C; Campos GRF; Ferreira HL; Sacchetto L; da Silva GCD; Parra MCP; Moraes MM; da Costa PI; Vasconcelos ATR; Spilki FR; Nogueira ML; Rahal P; Araujo JP
    Front Public Health; 2021; 9():745310. PubMed ID: 34660520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil.
    Camargo CH; Gonçalves CR; Pagnoca EVRG; Campos KR; Montanha JOM; Flores MNP; Soares MMCN; Binhardi FMT; Ferreira PM; Yu ALF; Carvalhanas TRMP; Abbud A; Bugno A; Sacchi CT
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115516. PubMed ID: 34425504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of SARS-CoV-2 and the L452R spike mutation using reverse transcription loop-mediated isothermal amplification plus bioluminescent assay in real-time (RT-LAMP-BART).
    Iijima T; Ando S; Kanamori D; Kuroda K; Nomura T; Tisi L; Kilgore PE; Percy N; Kohase H; Hayakawa S; Seki M; Hoshino T
    PLoS One; 2022; 17(3):e0265748. PubMed ID: 35312732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein.
    Kulkarni O; Narreddy S; Zaveri L; Kalal IG; Tallapaka KB; Sowpati DT
    Clin Infect Dis; 2021 Sep; 73(5):e1239-e1241. PubMed ID: 34492695
    [No Abstract]   [Full Text] [Related]  

  • 14. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.
    Soliman MS; AbdelFattah M; Aman SMN; Ibrahim LM; Aziz RK
    OMICS; 2021 Feb; 25(2):123-128. PubMed ID: 33253058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
    J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    Rani PR; Imran M; Lakshmi JV; Jolly B; Jain A; Surekha A; Senthivel V; Chandrasekhar P; Divakar MK; Srinivasulu D; Bhoyar RC; Vanaja PR; Scaria V; Sivasubbu S
    J Med Virol; 2021 Jul; 93(7):4163-4165. PubMed ID: 33818797
    [No Abstract]   [Full Text] [Related]  

  • 18. RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System.
    Raheja H; Das S; Banerjee A; P D; C D; Mukhopadhyay D; Ramachandra SG; Das S
    Microbiol Spectr; 2022 Aug; 10(4):e0078122. PubMed ID: 35862952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genomics and epidemiology of SARS-CoV-2 lineage].
    Sukegawa S; Takeuchi H
    Uirusu; 2021; 71(1):19-32. PubMed ID: 35526991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia.
    Sassi MB; Ferjani S; Mkada I; Arbi M; Safer M; Elmoussi A; Abid S; Souiai O; Gharbi A; Tejouri A; Gaies E; Eljabri H; Ayed S; Hechaichi A; Daghfous R; Gouider R; Khelil JB; Kharrat M; Kacem I; Alya NB; Benkahla A; Trabelsi S; Boubaker IB
    Infect Genet Evol; 2022 Aug; 102():105300. PubMed ID: 35552003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.